Skip to main content
logo
Citius Pharmaceuticals, Inc. (CTXR)
NASDAQ: CTXR · Real-Time Price · USD
0.4500
-0.0100 (-2.17%)
Oct 19, 2026, 11:04 AM EDT - Market open

Citius Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Oct - Sep.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Market Capitalization
122190109177296
Market Cap Growth
-47.65%-76.68%-16.79%-38.51%-40.33%413.63%
Enterprise Value
3197377130182
Last Close Price
0.461.2412.5217.1130.2550.75

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Forward PE
-1.378.717.117.117.88
PB Ratio
0.190.271.221.191.712.23
P/TBV Ratio
---4.925.194.67

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Debt / Equity Ratio
0.100.020.000.010.010.01
Net Debt / Equity Ratio
-0.13-0.03-0.04-0.28-0.40-0.52
Net Debt / EBITDA Ratio
-0.060.070.711.232.94
Net Debt / FCF Ratio
0.280.090.110.901.452.85
Quick Ratio
0.340.100.094.589.2117.60
Current Ratio
0.840.620.405.959.8418.29
Return on Equity (ROE)
-81.09%-52.42%-47.63%-33.40%-28.48%-27.70%
Return on Assets (ROA)
-26.57%-19.45%-23.83%-21.10%-16.24%-15.80%
Return on Capital Employed (ROCE)
-63.30%-44.80%-52.00%-37.50%-30.40%-17.00%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Earnings Yield
-366.43%-177.45%-43.26%-29.93%-19.03%-7.78%
FCF Yield
-276.11%-125.87%-31.17%-26.73%-16.04%-8.19%
Buyback Yield / Dilution
-154.35%-64.49%-11.16%-3.57%-34.52%-177.28%
SEC Filings: 10-K · 10-Q